| Product Code: ETC11395759 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Antisense RNAI Therapeutics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Antisense RNAI Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Antisense RNAI Therapeutics Market - Industry Life Cycle |
3.4 Israel Antisense RNAI Therapeutics Market - Porter's Five Forces |
3.5 Israel Antisense RNAI Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Antisense RNAI Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Antisense RNAI Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Antisense RNAI Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders in Israel |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Technological advancements in antisense RNAi therapeutics research and development |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Israel |
4.3.2 High cost associated with antisense RNAi therapeutics development and production |
4.3.3 Limited awareness and adoption of RNA interference technology among healthcare providers and patients in Israel |
5 Israel Antisense RNAI Therapeutics Market Trends |
6 Israel Antisense RNAI Therapeutics Market, By Types |
6.1 Israel Antisense RNAI Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Antisense RNAI Therapeutics Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Israel Antisense RNAI Therapeutics Market Revenues & Volume, By siRNA, 2021 - 2031F |
6.1.4 Israel Antisense RNAI Therapeutics Market Revenues & Volume, By miRNA, 2021 - 2031F |
6.1.5 Israel Antisense RNAI Therapeutics Market Revenues & Volume, By Antisense Oligonucleotides, 2021 - 2031F |
6.2 Israel Antisense RNAI Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Antisense RNAI Therapeutics Market Revenues & Volume, By Genetic Disorders, 2021 - 2031F |
6.2.3 Israel Antisense RNAI Therapeutics Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.2.4 Israel Antisense RNAI Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.3 Israel Antisense RNAI Therapeutics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Antisense RNAI Therapeutics Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
6.3.3 Israel Antisense RNAI Therapeutics Market Revenues & Volume, By Research Labs, 2021 - 2031F |
7 Israel Antisense RNAI Therapeutics Market Import-Export Trade Statistics |
7.1 Israel Antisense RNAI Therapeutics Market Export to Major Countries |
7.2 Israel Antisense RNAI Therapeutics Market Imports from Major Countries |
8 Israel Antisense RNAI Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials conducted for antisense RNAi therapeutics in Israel |
8.2 Investment in research and development for antisense RNAi therapeutics in Israel |
8.3 Number of partnerships and collaborations between Israeli biotech companies and international pharmaceutical firms in the RNAi therapeutics space. |
9 Israel Antisense RNAI Therapeutics Market - Opportunity Assessment |
9.1 Israel Antisense RNAI Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Antisense RNAI Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Antisense RNAI Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Antisense RNAI Therapeutics Market - Competitive Landscape |
10.1 Israel Antisense RNAI Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Israel Antisense RNAI Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here